$MYGN MYRIAD GENETICS INC Insider Trading Week 38/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MYRIAD GENETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MYRIAD GENETICS INC in week 38/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.12 | 75,864 | 2,285,024 | 8,790 | |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.12 | 3,000 | 90,360 | 84,654 | |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.12 | 2,346 | 70,662 | 0 | |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 23.11 | 4,328 | 100,020 | 0 | |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 16.53 | 1 | 17 | 0 | |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 13.28 | 5,324 | 70,703 | 0 | |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 12.17 | 5,808 | 70,683 | 0 | |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 9.04 | 664 | 6,003 | 0 | |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 8.63 | 13,128 | 113,295 | 0 | |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 38.08 | 75,864 | 2,889,098 | 48,128 | 124 K to 48.1 K (-61.18 %) |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.12 | 75,864 | 2,285,024 | 123,992 | 48.1 K to 124 K (+157.63 %) |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.98 | 3,000 | 113,940 | 48,128 | 51.1 K to 48.1 K (-5.87 %) |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.12 | 3,000 | 90,360 | 51,128 | 48.1 K to 51.1 K (+6.23 %) |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.51 | 13,128 | 492,431 | 48,128 | 61.3 K to 48.1 K (-21.43 %) |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 8.63 | 13,128 | 113,295 | 61,256 | 48.1 K to 61.3 K (+27.28 %) |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.51 | 664 | 24,907 | 48,128 | 48.8 K to 48.1 K (-1.36 %) |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 9.04 | 664 | 6,003 | 48,792 | 48.1 K to 48.8 K (+1.38 %) |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.34 | 5,808 | 216,853 | 48,128 | 53.9 K to 48.1 K (-10.77 %) |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 12.17 | 5,808 | 70,683 | 53,936 | 48.1 K to 53.9 K (+12.07 %) |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.34 | 5,324 | 198,782 | 48,128 | 53.5 K to 48.1 K (-9.96 %) |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 13.28 | 5,324 | 70,703 | 53,452 | 48.1 K to 53.5 K (+11.06 %) |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.51 | 2,346 | 87,998 | 48,128 | 50.5 K to 48.1 K (-4.65 %) |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.12 | 2,346 | 70,662 | 50,474 | 48.1 K to 50.5 K (+4.87 %) |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.34 | 4,328 | 161,595 | 48,128 | 52.5 K to 48.1 K (-8.25 %) |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 23.11 | 4,328 | 100,020 | 52,456 | 48.1 K to 52.5 K (+8.99 %) |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.34 | 1 | 37 | 48,128 | 48.1 K to 48.1 K (0.00 %) |
Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 16.53 | 1 | 17 | 48,129 | 48.1 K to 48.1 K (0.00 %) |
Sep 26 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.12 | 8,790 | 264,755 | 0 | |
Sep 26 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.98 | 8,790 | 333,844 | 48,128 | 56.9 K to 48.1 K (-15.44 %) |
Sep 26 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.12 | 8,790 | 264,755 | 56,918 | 48.1 K to 56.9 K (+18.26 %) |